Associate Director, FP&A
Lyell Immunopharma is a clinical-stage biotechnology company focused on advancing next-generation CAR T-cell therapies for patients with solid tumors and hematologic malignancies. The Associate Director, FP&A will play a pivotal role in leading the company's financial planning and analysis activities, ensuring alignment with Lyell's mission to develop innovative cancer treatments.
In this role, the Associate Director will oversee annual budgeting, quarterly forecasting, monthly financial reporting, variance analysis, financial modeling, and business performance management. They will collaborate closely with functional leaders across R&D, Clinical, G&A, and Commercial departments to develop and manage financial plans, understand key business drivers, monitor performance, and provide actionable financial insights to support effective resource allocation and decision-making.
Candidates should possess a Bachelor's degree in Accounting or Finance, with an MBA or related advanced degree preferred. A minimum of 8 years of progressive experience in FP&A or financial planning is required, including at least 5 years in the biotechnology or pharmaceutical industry. Proficiency in financial modeling, Excel, and a strong understanding of FP&A principles are essential. Experience with FP&A systems, data integration, reporting, and process automation is also preferred.
The compensation package includes an annual salary ranging from $170,000 to $210,000, with the opportunity to earn an annual bonus. Employees are also eligible to participate in Lyell's Equity Incentive Plan. Additional benefits and perks are offered to support employee well-being and professional growth.
Lyell Immunopharma fosters a culture based on Science, Respect, Collaboration, and Courage, reflecting the company's commitment to innovation and excellence. The Associate Director, FP&A will have opportunities to contribute to the company's growth and success, working alongside a dedicated team to advance cutting-edge cancer therapies.